Skip to main content
. 2019 Jul 19;10:3211. doi: 10.1038/s41467-019-11193-x

Fig. 5.

Fig. 5

In vivo antitumor efficacy of prodrug nanoassemblies. (a) Tumor volume. (b) Tumor burden. (c) Images of tumors. (d) Body weight changes. Data are presented as mean ± SD (five independent experiments). *P< 0.05, **P< 0.01 by two-tailed Student’s t test. (e) Hepatorenal function parameters. Data are presented as mean ± SD (three independent experiments). AST: aspartate aminotransferase (U L−1); ALT: alanine aminotransferase (U L−1), BUN: blood urea nitrogen (mmol L−1), CREA: creatinine (μmol L−1)